HOME >> BIOLOGY >> NEWS
Jefferson researchers develop combined procedure for uterine preservation in treating fibroids

Although fibroidsbenign tumors that grow in the uteruscan cause pelvic pain, abnormal vaginal bleeding and infertility, women of childbearing age often choose to forego treatment because the available treatment options dont guarantee fertility.

In a study in the December issue of The Female Patient, physicians at Thomas Jefferson University Hospital in Philadelphia present a case history of a 35-year-old women whose numerous fibroids formed a large mass in her pelvic area that, when initially diagnosed, was of a size comparable to a full-term pregnancy.

"Traditionally, treatment for such a large fibroid mass in the uterus has been limited to hysterectomy, because the patient would bleed extensively if an attempt was made to merely remove the fibroids." says Jay Goldberg, M.D., MSCP, lead author and director of the Jefferson Fibroid Center at Thomas Jefferson University. "In this particular case though, hysterectomy was not an option because the patient strongly desired future fertility and uterine preservation."

To meet the patients wishes and remove the fibroids, the physicians developed a plan to perform two procedures a month apart.

The Jefferson physicians first performed a uterine fibroid embolization (UFE), a minimally invasive radiologic procedure that blocks the arteries that supply blood to the fibroid tumors. The procedure was done to reduce the blood flow within the patients uterus and the risk of hemorrhaging at the time of surgery.

One month later, the patient underwent an abdominal myomectomy. In this procedure, the fibroids are removed through an abdominal skin incision. After the UFE, her initially 38-week sized uterus had decreased to a 34-week size, with decreased blood flow. Eleven large fibroids were removed during the myomectomy, with minimal blood loss. The patient was discharged from the hospital on the second day post-surgery and experienced no complications.

Dr. Goldberg,
'"/>

Contact: Nan Myers
nan.myers@jefferson.edu
215-955-6300
Thomas Jefferson University
5-Dec-2006


Page: 1 2

Related biology news :

1. Jefferson scientists patent dramatically improves
2. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
3. Tiny genes may increase cancer susceptibility, Jefferson scientists find
4. Jefferson scientists use gene therapy to reverse heart failure in animals
5. Jefferson researchers discovery may change thinking on how viruses invade the brain
6. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
7. Jefferson scientists find rabies-based vaccine could be effective against HIV
8. Jefferson scientists uncover gene mutation that cuts colon polyps, may suppress cancer
9. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
10. Jefferson scientists find guardian genes choices crucial to stopping cancer process
11. Jefferson researchers uncover new way nature turns genes on and off

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2020)... ... April 21, 2020 , ... Captis Biotechnology, Inc. announced ... that provides patent development support for early stage startups. The investment will support ... ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical technology. , ...
(Date:4/18/2020)... ... April 16, 2020 , ... SIRION Biotech GmbH , a world ... it will present a company update on its work expediting gene therapy research and ... on April 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, will also ...
(Date:4/16/2020)... , ... April 15, 2020 , ... ... working cell banks and hMSC bioprocess systems, announces that the Medical Technology Enterprise ... at MTEC’s 4th Annual Membership Meeting in March. The Regenerative Medicine (RegenMed) biomanufacturing ...
Breaking Biology News(10 mins):
(Date:4/22/2020)... WEST CHESTER, Ohio (PRWEB) , ... April 21, ... ... availability of Biophen™ FXIII chromogenic method for determination of FXIII. , Aniara Diagnostica, ... has strengthened its commitment to meeting today’s highest standards for product quality and ...
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow ... Innovation Research (SBIR) program to support the expansion of its digital health platform ... which conducts a rigorous merit-based review process, adds to NeuroFlow’s recent government ...
(Date:4/7/2020)... ... 06, 2020 , ... Red Nucleus, a leading provider of ... the release of at-home virtual learning resources for all client partners. , “With ... of our employees as we continue to implement measures to safeguard the well-being ...
(Date:4/1/2020)... (PRWEB) , ... March 30, 2020 , ... ... and telehealth developer Reliant Immune Diagnostics (RID), formed earlier this year to bring ... pandemic by creating in-home tests for COVID-19. Company officials are currently?awaiting an Emergency ...
Breaking Biology Technology:
Cached News: